[1] Wang H, Xu L, Zhao L, et al.Literature Analysis of 126 Cases of Adverse Drug Reactions Induced by Oxaliplatin[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2019, 16(2): 110-114. [2] Georg Lenz, Ulrich T. Hacker,Wolfgang Kern., et al.Adverse reactions to oxaliplatin: a retrospective study of 25 patients treated in one institution[J].Anti-cancer Drug, 2003, 14(9):731-733. [3] MaindraultGoebel F, André T, Tournigand C,et al.Allergic-type reactions to oxaliplatin: Retrospective analysis of 42 patients[J]. Eur J Cancer, 2005, 41(15): 2262-2267. [4] Ichikawa Y, Goto A, Hirokawa S,et al.Allergic Reactions to Oxaliplatin in a Single Institute in Japan[J].Jpn J Clin Oncol, 2009, 39(9): 616-620. [5] Song QY,Li T.Oxaliplatin induced anaphylaxis in 1 patient[J]. China Practical Medicine(中国实用医药), 2014, 9(3):195-196. [6] Li HH.Anaphylaxis induced by oxaliplatin for injection in 1 case[J]. China Medical Herald(中国医药导报), 2011, 8(13): 130. [7] Basketter D A, McFadden J P, Kimber I.Assessing the severity of allergic reactions: a regulatory dilemma[J].Contact Dermatitis, 2012, 67(1): 3-8. [8] Mori Y, Nishimura T, Kitano T,et al.Oxaliplatin-free interval as a risk factor for hypersensitivity reaction among colorectal cancer patients treated with FOLFOX[J].Oncology, 2010, 79(1-2): 136-143. [9] Siu SWK, Chan RTT, Au GKH.Hypersensitivity reactions to oxaliplatin: experience in a single institute[J]. Official Journal of the European Society for Medical Oncology, 2006, 17(2): 259-261. [10] Micheli L, Mattoli L, Maidecchi A,et al.Effect of Vitis vinifera hydroalcoholic extract against oxaliplatin neurotoxicity: in vitro and in vivo evidence[J].Sci Rep, 2018, 8(1): 14364. [11] Lee K, Park Y J, Kim E S,et al.Hypersensitivity Reactions to Oxaliplatin[J].Cancer Res Treat, 2006, 38(4): 240-241. [12] Kim BH, Bradley T, Tai J,et al.Hypersensitivity to Oxaliplatin: An Investigation of Incidence and Risk Factors, and Literature Review[J].Oncology, 2009, 76(4): 231-238. [13] Zeng PH, Shu LL, Xie XH, et al.Comparative analysis of clinical and endoscopic data of colorectal cancer patients of different ages[J].The New Med, 2005(8): 451-453. [14] Zhao B, Zhong HG,Gao F, et al.Epidemiological analysis of 3720 cases of colorectal cancer in Guangxi[J].Guangdong Medical, 2013, 34(14): 2239-2242. [15] Rogers BB, Cuddahy T, Briscella C,et al.Oxaliplatin: Detection and Management of Hypersensitivity Reactions[J].Clin J Oncol Nurs, 2019, 23(1): 68-75. [16] Brandi G, Pantaleo M A, Galli C,et al.Hypersensitivity reactions related to oxaliplatin (OHP)[J].Brit J Cancer, 2003, 89(3): 477-481. [17] Castells MCMP, Tennant NMB, Sloane DEM,et al.Hypersensitivity reactions to chemotherapy: Outcomes and safety of rapid desensi-tization in 413 cases[J].J of Allerg and Clin Immunol, 2008, 122(3): 574-580. [18] Zhang X, Zhao Y, Dong Y.The Effects of Prolonged Infusion on Reducing Oxaliplatin Hypersensitivity Reactions[J].J Investig Allergol Clin Immunol, 2017, 27(1): 65-66. [19] Li Xiaotong,Zhai Suodi,Wang Qiang,et al.First aid guide for severe allergic reactions[J].Adverse Drug Reactions Journal, 2019, 21(2): 85-91. [20] Parel M, Ranchon F, Nosbaum A, et al.Hypersensitivity to oxaliplatin: clinical features and risk factors[J].Bmc Pharmacol Toxicol, 2014, 15: 1. [21] Xu Y, Chen L, Zhu H, et al.Rationality and Safety of Oxaliplatin Prescription[J]. Chinese Journal of Pharmacovigilance(中国药物警戒),2016,13(3):176-179. [22] Waddle M, Irvin M, Gupta E,et al.Acute Disseminated Intravascular Coagulation after Oxaliplatin Infusion[J].Chemother, 2017, 62(5): 295-300. [23] Lai J, Wang W.Acute hemolysis after receiving oxaliplatin treatment: a case report and literature review[J].Pharmacy World & Science, 2009, 31(5): 538-541. [24] Garciaz S, Oziel-Taieb S, Dermeche S,et al.Acute immune hematological complication of oxaliplatin. A series of 3 cases[J]. Tumori, 2014, 100(1): 17-19. [25] Yamauchi H, Goto T, Takayoshi K,et al.A retrospective analysis of the risk factors for allergic reactions induced by the administration of oxaliplatin[J].Eur J Cancer Care, 2015, 24(1): 111-116. [26] Nishihara M, Nishikura K, Morikawa N,et al.Factors Influencing the Appearance of Oxaliplatin-Induced Allergy[J].Biol Pharm Bull, 2017, 40(12): 2105-2109. [27] Bonadonna MPP.Skin Test Protocol for the Prevention of Hypers-ensitivity Reactions to Oxaliplatin[J].Anti-cancer Res, 2014, 34: 537-540. [28] Nozawa HMP, Muto YMP, Yamada YMP.Desensitization to oxaliplatin with two stages of premedication in a patient with metastatic rectal cancer[J].Clin Ther, 2008, 30(6): 1160-1165. [29] Rose PG, Metz C, Link N.Desensitization With Oxaliplatin in Patients Intolerant of Carboplatin Desensitization[J].Intern J of Gynecol Cancer, 2014, 24(9): 1603-1606. [30] Takako Y, Iwasa S, Hashimoto H.Successful Rechallenge for Oxaliplatin Hypersensitivity Reactions in Patients with Metastatic Colorectal Cancer[J].Anti-cancer Res, 2012, 32: 5521-5526. [31] Lydia Mis,Nishan HF,Hurbert IH,et al.Successful Desens-itization to Oxaliplatin[J].The Annals of Pharmacotherapy, 2005, 39: 966-969. |